The Food and Drug Administration said Kim Kardashian’s Instagram post praising a morning-sickness drug was “false or misleading in that it presents efficacy claims for Diclegis, but fails to communicate any risk information.”
from WSJ.com: US Business http://ift.tt/1J4FAgG
via IFTTT
No comments:
Post a Comment